| Natalie L Drake, MD | |
|
17350 St Lukes Way Ste 350, The Woodlands, TX 77384-4103 | |
| (281) 203-5115 | |
| (281) 203-5119 |
| Full Name | Natalie L Drake |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 26 Years |
| Location | 17350 St Lukes Way Ste 350, The Woodlands, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093731747 | NPI | - | NPPES |
| 2696355 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VG0400X | Obstetrics & Gynecology - Gynecology | L0256 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oncology Specialists Of Texas, Pllc | 7416295829 | 2 |
News Archive
About 500,000 babies are born premature in the United States each year, according to the U.S. National Library of Medicine. Those infants, born before 37 weeks of gestation, will likely deal with the threat of numerous complications or even death.
Trevena Inc., the leader in G-protein coupled receptor biased ligand drug discovery, today announced the initiation of a Phase 2a clinical trial with its lead program, TRV120027, a beta-arrestin biased angiotensin II type 1 receptor ligand, the first biased ligand designed to treat patients with acute heart failure.
A label showing added sugars content on all packaged foods and sugary drinks could have substantial health and cost-saving benefits in the United States over the next 20 years, according to a new study published in the American Heart Association's journal Circulation.
The U.S. Food and Drug Administration today approved a new indication for Sprycel (dasatinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase chronic myeloid leukemia (Ph+ CP-CML), is a slowly progressing blood and bone marrow disease linked to a genetic abnormality.
› Verified 4 days ago
| Entity Name | Oncology Specialists Of Texas, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376017715 PECOS PAC ID: 7416295829 Enrollment ID: O20190211001132 |
News Archive
About 500,000 babies are born premature in the United States each year, according to the U.S. National Library of Medicine. Those infants, born before 37 weeks of gestation, will likely deal with the threat of numerous complications or even death.
Trevena Inc., the leader in G-protein coupled receptor biased ligand drug discovery, today announced the initiation of a Phase 2a clinical trial with its lead program, TRV120027, a beta-arrestin biased angiotensin II type 1 receptor ligand, the first biased ligand designed to treat patients with acute heart failure.
A label showing added sugars content on all packaged foods and sugary drinks could have substantial health and cost-saving benefits in the United States over the next 20 years, according to a new study published in the American Heart Association's journal Circulation.
The U.S. Food and Drug Administration today approved a new indication for Sprycel (dasatinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase chronic myeloid leukemia (Ph+ CP-CML), is a slowly progressing blood and bone marrow disease linked to a genetic abnormality.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Natalie L Drake, MD 6700 Woodlands Pkwy Ste 230-151, The Woodlands, TX 77382-2575 Ph: (281) 203-5115 | Natalie L Drake, MD 17350 St Lukes Way Ste 350, The Woodlands, TX 77384-4103 Ph: (281) 203-5115 |
News Archive
About 500,000 babies are born premature in the United States each year, according to the U.S. National Library of Medicine. Those infants, born before 37 weeks of gestation, will likely deal with the threat of numerous complications or even death.
Trevena Inc., the leader in G-protein coupled receptor biased ligand drug discovery, today announced the initiation of a Phase 2a clinical trial with its lead program, TRV120027, a beta-arrestin biased angiotensin II type 1 receptor ligand, the first biased ligand designed to treat patients with acute heart failure.
A label showing added sugars content on all packaged foods and sugary drinks could have substantial health and cost-saving benefits in the United States over the next 20 years, according to a new study published in the American Heart Association's journal Circulation.
The U.S. Food and Drug Administration today approved a new indication for Sprycel (dasatinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase chronic myeloid leukemia (Ph+ CP-CML), is a slowly progressing blood and bone marrow disease linked to a genetic abnormality.
› Verified 4 days ago
John Wakefield Durst, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1001 Medical Plaza Dr Ste 280, The Woodlands, TX 77380 Phone: 281-363-4450 Fax: 281-292-3462 | |
Jennifer Honeycutt Breazeale, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 17198 St Lukes Way, Suite 540, The Woodlands, TX 77384 Phone: 713-442-1900 | |
Dr. Jon M Rawson, M.D. PH.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1001 Medical Plaza Dr Ste 280, The Woodlands, TX 77380 Phone: 281-363-4445 Fax: 281-292-4419 | |
Christina Nestlerode, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 17198 St Lukes Way Ste 440, The Woodlands, TX 77384 Phone: 936-266-2500 | |
Latoia Monneque Marks, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 17198 St. Luke's Way, The Woodlands, TX 77384 Phone: 936-266-2500 | |
Dr. Erica Ruth Chapman, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 17198 St Lukes Way Ste 540, The Woodlands, TX 77384 Phone: 713-442-1900 |